¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"I region associated antigens"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • conserved region
    º¸Á¸ºÎÀ§
  • constant region
    ºÒº¯ºÎÀ§
  • critical region
    1. °áÁ¤ÀûºÎÀ§ 2. ±â°¢¿ª
  • deltoid region
    ¾î±ú¼¼¸ð±ÙºÎÀ§, »ï°¢±ÙºÎÀ§
  • epigastric region
    ¸íÄ¡ºÎÀ§
  • frontal region
    À̸¶ºÎÀ§, ÀüµÎºÎ
  • gluteal region
    º¼±âºÎÀ§, º¼±â, µÐºÎ
  • hypervariable region
    °íº¯À̺ÎÀ§
  • hypochondriac region
    °¥ºñ¹ØºÎÀ§, ´ÁÇϺÎ
  • hinge region
    °æÃ¸ºÎÀ§, µ¹Â¼±âºÎÀ§
  • infratemporal region
    °üÀھƷ¡ºÎÀ§, ÃøµÎÇϺÎ
  • inguinal region
    »ô±¼ºÎÀ§, ¼­ÇýºÎ
  • interscapular region
    ¾î±ú»çÀ̺ÎÀ§, °ß°©°£ºÎ
  • lumbar region
    Ç㸮ºÎÀ§, ¿äºÎ
  • mammary region
    À¯¹æºÎÀ§
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • variable region
    °¡º¯ºÎÀ§
  • vestibular region
    ¾È¶ãºÎÀ§, ÀüÁ¤ºÎ
  • zygomatic region
    ±¤´ëºÎÀ§
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • condylar region
    °üÀýÀ¶±âºÎÀ§
  • conserved region
    º¸Á¸À¯ÀüÀÚ
  • constant region
    ºÒº¯ºÎÀ§
  • critical region
    °áÁ¤ÀûºÎÀ§, ±â°¢¿ª
  • deltoid region
    ¾î±ú¼¼¸ð±ÙºÎÀ§
  • epigastric region
    ¸íÄ¡ºÎÀ§
  • frontal region
    À̸¶ºÎÀ§
  • gluteal region
    º¼±âºÎÀ§, º¼±â
  • hinge region
    °æÃ¸ºÎÀ§, µ¹Â¼±âºÎÀ§
  • hypervariable region
    °íº¯À̺ÎÀ§
  • hypochondriac region
    °¥ºñ¾Æ·¡ºÎÀ§
  • infratemporal region
    °üÀھƷ¡ºÎÀ§, ÃøµÎÇϺÎ
  • inguinal region
    »ô±¼ºÎÀ§
  • interscapular region
    ¾î±ú»çÀ̺ÎÀ§
  • lumbar region
    ¿·±¸¸®ºÎÀ§, ¿äºÎ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • granulocyte-specific antigens
    °ú¸³±¸Æ¯ÀÌÇ׿ø
  • histocompatibility antigens
    Á¶Á÷ÀûÇÕ Ç׿ø
  • platelet-specific antigens
    Ç÷¼ÒÆÇƯÀÌÇ׿ø
  • D region
    D¿µ¿ª (H-2Á¶Á÷Ç׿øÀÇ)
  • ROI(region of interest)
    °ü½É ¿µ¿ª
  • ROI, see region of interest
    °ü½É¿µ¿ª
  • abdominal region
    º¹ºÎ(º¹ºÎ).
  • anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
  • arctic region
    ºÏ±Ø±¸(ËÓ˻˴).
  • foveal region of retina
    ¸Á¸·Á߽ɿÍ(ØÑدñéãýèÀ).
  • foveal region of retina
    ¸Á¸·Á߽ɿÍ(ØÑدñéãýèÀ), ¸Á¸·Á߽ɿÀ¸ñ
  • framework region
    ±âº»Æ²ºÎÀ§
  • framework region in immunoglobulin
    ¸é¿ª±Û·ÎºÒ¸°°ñ°ÝºÎ
  • glottic region
    ¼º¹®¿ª
  • gluteal region
    º¼±â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • associated antagonist
    °ø¾×±æÇ×¹°Áú.
  • associated movement
    ¿¬Çտ
  • associated psychosis
    ¼ö¹Ý(âËÚᣩÁ¤½Åº´
  • cell associated antigen
    ¼¼Æ÷¿¬°üÇ׿ø
  • cell-associated antibody
    ¼¼Æ÷°áÇÕÇ×ü(á¬øàÌ¿ùêù÷ô÷), ¼¼Æ÷°íÁ¤Ç×ü, ¼¼Æ÷°ü ·ÃÇ×ü.
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·çÇÁ°ü·Ã¹ÙÀÌ·¯½º
  • dialysis-associated cystic disease of kidney
    ½Å(ãì)ÀÇ Åõ¼®(÷âà°) ¿¬°ü¼º ³¶¼ºÁúȯ
  • fetal tumor-associated antigen
    ÅÂ¾Æ Á¾¾ç °ü·Ã Ç׿ø
  • gut-associated lymphatic tissue (GALT)
    Àå-¿¬°ü ¸²ÇÁÁ¶Á÷
  • intrafacial associated movement
    ¾È¸é½Å°æ³»¿¬Çտ(äÔØüãêÌèÒ®ææùêê¡ÔÑ).
  • lateral cord and associated anterior cornual syndrome
    Ãø»èµ¿ÃøÀü°¢ÁõÈıº (ö°ßãÔÒö°îñÊÇñøý¦ÏØ).
  • lymphedema-associated angiosarcoma
    ¸²ÇÁºÎÁ¾°ü·Ã ¸Æ°üÀ°Á¾(¡­Î¼Ö¤ ØæÎ·ë¿ðþ)
  • lymphoma,mucosa-associated lymphoid tissue
    Á¡¸·°ü·Ã ¸²ÇÁÁ¶Á÷(ïÄØ¯Î¼Ö¤ ¡­ðÚòÄ)
  • mucosa-associated lymphoid tissue
    Á¡¸·¿¬°ü¸²ÇÁÁ¶Á÷(¡­æáμ¡­ðÚòÄ)
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Gluteal region
    º¼±â
    [¿¾ ¿ë¾î] µÐºÎ
  • Buccal region
    º¼ºÎÀ§
    [¿¾ ¿ë¾î] ÇùºÎ
  • Inguinal region
    »ô±¼ºÎÀ§
    [¿¾ ¿ë¾î] ¼­ÇýºÎ
  • Deltoid region
    ¼¼¸ð±ÙºÎÀ§
    [¿¾ ¿ë¾î] »ï°¢±ÙºÎ
  • Lateral hypothalamic region
    ½Ã»óÇϺΰ¡Âʱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺοÜÃøºÎ
  • Posterior hypothalamic region
    ½Ã»óÇϺεڱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÈĺÎ
  • Dorsal hypothalamic region
    ½Ã»óÇϺεîÂʱ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺιèÃøºÎ
  • Anterior hypothalamic region
    ½Ã»óÇϺξձ¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÀüÃøºÎ
  • Intermediate hypothalamic region
    ½Ã»óÇϺÎÁß°£±¸¿ª
    [¿¾ ¿ë¾î] ½Ã»óÇϺÎÁß°£ºÎ
  • Premaxillary region
    ¾ÕÀ§ÅκÎÀ§
    [¿¾ ¿ë¾î] »ó¾ÇÀüºÎ
  • Scapular region
    ¾î±ú»ÀºÎÀ§
    [¿¾ ¿ë¾î] °ß°©ºÎ
  • Infrascapular region
    ¾î±ú¾Æ·¡ºÎÀ§
    [¿¾ ¿ë¾î] °ß°©ÇϺÎ
  • Sacrococcygeal region
    ¾ûÄ¡²¿¸®ºÎÀ§
    [¿¾ ¿ë¾î] õ¹ÌºÎ
  • Sacral region
    ¾ûÄ¡ºÎÀ§
    [¿¾ ¿ë¾î] õ°ñºÎ
  • Lumbar region
    ¿·±¸¸®ºÎÀ§
    [¿¾ ¿ë¾î] ¿äºÎ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hinge region
    µ¹Â¼±Í ±¸¿ª (Ï¡æ´)
  • hv region
    hv ±¸¿ª(Ï¡æ´)
  • intercistronic region
    ½Ã½ºÆ®·Ð°£ ±¸¿ª(Ï¡æ´)
  • K region
    K ±¸¿ª(Ï¡æ´)
  • L region
    L ±¸¿ª(Ï¡æ´)
  • proportional region
    ºñ·Ê±¸¿ª(ÝïÖÇÏ¡æ´)
  • S region
    S ºÎÀ§(Ý»êÈ)
  • sticky region
    Á¡Âø ±¸¿ª (ïÄó·Ï¡æ´)
  • variable region
    °¡º¯ºÎÀ§(ʦܨݻêÈ)
  • V region
    V ºÎÀ§ (Ý»êÈ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CREG Cross REactive Group (of HLA Antigens)
ANA acetylneuraminic acid; American Narcolepsy Association; American Neurological Association; American ...
CD cadaver donor; canine distemper; canine dose; carbohydrate dehydratase; carbon dioxide; cardiac dise...
AAN AIDS-associated nephropathy; alpha-amino nitrogen; American Academy of Neurology; American Academy o...
DAA decompensated autonomous adenoma; dementia associated with alcoholism; dialysis-associated amyloidos...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
MAIPA Monoclonal Antibody-specific Immobilisation of Platelet Antigens
Ia I region associated
MAR matrix associated region
SAR scaffold associated region
3"-UTR 3"-untranslated region
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • denervated peripheral region
    Å»½Å°æ ¸»ÃÊ ¿µ¿ª
  • framework region
    ±âº» Ʋ
  • infraglottic region
    ¼º¹® ÇϺÎ
  • lateral abdominal region
    Ãøº¹ºÎ
  • lateral hypothalamic region
    ½Ã»ó ÇϺΠ°¡ÂÊ ±¸¿ª
  • lip border region
    ÀÔ¼ú º¯¿¬ ºÎÀ§
  • medial thalamic region
    ³»Ãø ½Ã»ó ¿µ¿ª
  • mental region
    ÅÎ ³¡ ºÎÀ§, ¾Æ·¡ ÅÎ ºÎ
  • molar region
    ´ë±¸Ä¡ ºÎÀ§
  • multiple region
    ´Ù¹ß¼º ºÎÀ§
  • nasolabial region
    ºñ¼ø ºÎÀ§
  • nuchal region
    ¸ñ´ú¹Ì ºÎÀ§
  • occipital region
    ÈĵΠºÎºÐ, ÈĵκÎ
  • oral region
    ±¸°­ ¿µ¿ª, ÀÔ ºÎÀ§, ±¸ºÎ
  • palate tuberosity region
    ±¸°³ °áÀý ºÎÀ§
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Cdc42Hs-associated kinase <enzyme> Specifically binds cdc42hs in its GTP-bound form; 379 aa residues, mw 45 kD; aa sequence given in first source
Registry number: EC 2.7.1.-
(26 Jun 1999)
megakaryocyte-associated tyrosine kinase <enzyme> Genbank l18974
Registry number: EC 2.7.1.-
Synonym: matk protein, csk homologous kinase, chk enzyme
(26 Jun 1999)
Rho-associated kinase <enzyme> Binds the g-protein rho; rock-i and rock-ii are two isoforms; genbank u36909
Registry number: EC 2.7.10.-
Synonym: rho-kinase, rock-i, rock-ii, p160(rock), let-502 kinase
(26 Jun 1999)
growth associated proteins <growth factor> Group of developmentally regulated polypeptides thought to be critical for the formation of neural circuitry. The acidic membrane phosphoprotein GAP 43 is synthesised and transported down regenerating and developing axons, pp46 localised in growth cone membranes during embryogenesis, B 50 in mature presynaptic membranes in the regulation of phosphotidylinositol turnover and F1 in the hippocampus during long-term potentiation, are now all known to be the same protein.
(18 Nov 1997)
RLK5-associated protein phosphatase <enzyme> Associated with serine-threonine receptor-like kinase, rlk5; from arabidopsis thaliana; composed of 3 domains, an amino-terminal signal anchor, a kinase interaction domain and a type 2c protein phosphatase catalytic domain; mw 65 kD; genbank u09505
Registry number: EC 3.1.3.-
Synonym: kapp, kinase-associated protein phosphatase
(26 Jun 1999)
gut-associated lymphoid tissue <physiology> Peripheral lymphoid organ consisting of lymphoid tissue associated with the gut (Peyer's patches, tonsils, mesenteric lymph nodes and the appendix).
It is especially rich in B-cells and is responsible for localised immunity to pathogens such as bacteria, viruses, and parasites.
(20 Sep 2002)
Rous-associated virus A leukaemia virus of the leukosis-sarcoma complex which by phenotypic mixing with a defective (noninfectious) strain of Rous sarcoma virus effects production of infectious sarcoma virus with envelope antigenicity of the RAV.
(05 Mar 2000)
microtubule-associated protein 1B kinase <enzyme> Serine-threonine-specific protein kinase which acts on microtubule-associated protein 1b (map1b); activated by various mitogens; does not act on map2
Registry number: EC 2.7.10.-
Synonym: map1b kinase
(26 Jun 1999)
microtubule-associated protein-2 phosphatase <enzyme> does not fit into any of the classes of protein phosphatases (types 1,2a,2b and 2c) involved in cellular regulation
Registry number: EC 3.1.3.-
Synonym: map-2 phosphatase
(26 Jun 1999)
microtubule-associated proteins <protein> High molecular weight proteins found in the microtubules of the cytoskeletal system. Under certain conditions they are required for tubulin assembly into the microtubules and stabilise the assembled microtubules.
Acronym: MAP
(12 Dec 1998)
myelin-associated glycoprotein A myelin protein found in the periaxonal membrane of both the central and peripheral nervous systems myelin sheaths. It has a structure that is similar to members of the ig superfamily that participate in cell adhesion.
(12 Dec 1998)
croup-associated virus parainfluenza virus type 2
pregnancy-associated alpha-plasma protein An alpha 2-macroglobulin, molecular weight approximately 750,000 now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during the second trimester and continue to rise until the end of gestation.
(12 Dec 1998)
pregnancy-associated beta-plasma protein A beta-globulin now believed to be a pregnancy-specific protein. Its plasma levels increase steadily during pregnancy until the end of gestation.
(12 Dec 1998)
pregnancy-associated esterase <enzyme> In baboons, amount of activity correlates with stage of pregnancy; hydrolyzes alpha-naphthyl butyrate in preference to alpha-naphthyl acetate
Registry number: EC 3.1.1.-
Synonym: pregnancy esterase
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á